Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Common Equity (2023 - 2026)

Hinge Health's Common Equity history spans 3 years, with the latest figure at $178.7 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 141.11% to $178.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $178.7 million, a 141.11% increase, with the full-year FY2025 number at $178.7 million, up 141.11% from a year prior.
  • Common Equity hit $178.7 million in Q4 2025 for Hinge Health, down from $208.0 million in the prior quarter.
  • Over the last five years, Common Equity for HNGE hit a ceiling of $208.0 million in Q3 2025 and a floor of -$462.6 million in Q2 2024.
  • Historically, Common Equity has averaged -$174.6 million across 3 years, with a median of -$424.0 million in 2023.
  • Biggest five-year swings in Common Equity: decreased 2.49% in 2024 and later skyrocketed 145.04% in 2025.
  • Tracing HNGE's Common Equity over 3 years: stood at -$424.0 million in 2023, then fell by 2.49% to -$434.6 million in 2024, then skyrocketed by 141.11% to $178.7 million in 2025.
  • Business Quant data shows Common Equity for HNGE at $178.7 million in Q4 2025, $208.0 million in Q3 2025, and $173.8 million in Q2 2025.